Warning: array_key_exists(): The first argument should be either a string or an integer in D:\Inetpub\webs\924517_web\www\lang_set.inc.php on line 7 Prof. MUDr. Cyril Höschl DrSc. FRCPsych.

Abstracts

Previous | 1 | 2 | 3  Move down


  1. Brunovsky M, Bares M, Kopecek M, Novak T, Stopkova P, Sos P, Hoschl C.Early prediction of therapeutic response by prefrontal QEEG cordance in patients with treatment-resistant depression. A pooled analysis. Int J Neuropsychopharmacol 13, 2010;S1:144
  2. Höschl C.: Emotions from the psychiatric point of view. 3rd Interdisciplinary Medical Congress of the Czech Medical Academy "Emotions in medicine". Karlovy Vary (Carlsbad), 26-28 Nov 2010
  3. Horacek J, Flegr J, Tintera J, Novak T, Brunovsky M, Bubenikova-Valesova V, Palenicek T, Höschl C. Latent Toxoplasmosis Reduces Gray Matter Density in Schizophrenia but not in Controls. Voxel-Based-Morphometry (VBM) Study. 49th Annual Meeting of American College of Neuropsychopharmacology, Miami, FL, USA December 5-9, 2010
  4. Höschl C. Is the use of placebo necessary for objectivity of clinical trials? Psychiatrie 15, 2011; S1:19
  5. Hajek T, Cullis J, Blagdon R, Propper L, Duffy A, Kopecek M, Novak T, Höschl C, Alda M. Increased right inferior frontal gyrus gray matter in 2 cohorts of unaffected and affected offspring of bipolar parents – replication design, high-risk study. 9th international conference on bipolar disorder, Pittsburg, June 9-11, 2011
  6. Horacek J, Flegr J, Holub D, Tintera J, Novak T, Brunovsky M, Höschl C. Different impact of T.gondii seropositivity on the brain morphometry in schizophrenia and healthy control groups. Eur Psychiatry 26, 2011, S1 [epub]
  7. Höschl C, Fialová L. EPA Guidance on Conflicts of Interests. Eur Psychiatry 26, 2011, S1 [epub]
  8. Bares M, Novak T, Kopecek M, Stopkova P, Höschl C. Is serum folate level a predictor of response in depressive patients who failed to previous antidepressant treatments? A naturalistic study. Eur Psychiatry 26, 2011, S1 [epub]
  9. Höschl C, Bareš M, Novák T, Kopeček M, Stopková P: Efficacy of combinations of antidepressants in the treatment of resistant depression. Eur Psychiatry 26, 2011, S1 [epub]
  10. Höschl C. Is the use of placebo in clinical trials inevitable? Abstracts, XXVI. Czech and Slovak days of young neurologists, 12-13 May 2011, hotel Jana, Přerov. Neurologie pro praxi, 2011;12(Suppl.C):8
  11. Höschl C, Bareš M, Brunovský M, Kopeček M, Novák T, Kožený J. Prediction of a therapeutic response to antidepressants. Abstracts, 10th World Congress of Biological Psychiatry, 29 May- 2 June 2011, Prague
  12. Höschl C, Pálová E. Psychiatry and public health. In: "Strenghtening the system of public health". Abstract book of the 4th meeting of SAVEZ with international participation. 9-10 June 2011, Košice, Slovakia.
  13. Bares M, Novak T, Kopecek M, Stopkova P, Cermak J, Kozeny J, Höschl C. Antidepressant combinations and monotherapy in the treatment of resistant depression: a randomised, open-label study. Poster at 24th ECNP Congress in Paris, 5 September 2011.
  14. Horacek J, Flegr J, Tintera J, Verebova K, Spaniel F, Novak T, Brunovsky M, Bubenikova-Valesova V, Holub D, Palenicek T, Höschl C. Latent toxoplasmosis reduces gray matter density in schizophrenia but not in controls. Cutting Edge Psychiatry in Practice, 2011;1, S1:159. ISSN 2047-1882
  15. Höschl C. Placebo – deception or indispensable tool? Cutting Edge Psychiatry in Practice, 2011;1, S1:151. ISSN 2047-1882
  16. Höschl C. Basic concepts of schizophrenia: experimental approaches. Bull Clin Psychopharmacol 2011; 21 (Suppl. 2):548-549
  17. Horacek J, Bubenikova Valesova V, Palenicek T, Spaniel F, Höschl C. The ins and outs of the human model of schizophrenia. Bull Clin Psychopharmacol 2011; 21 (Suppl. 2):549
  18. Horáček J, Tintěra J, Ibrahim I, Holec M, Verébová K, Mikoláš P, Höschl C. Use of fMRI in assessment of emotional stimuli processing. In: 7th International workshop on functional magnetic resonance. Olomouc, Palacky University, 2011; p. 22 (abstract).
  19. Hajek T, Cullis J, Blagdon R, Duffy A, Propper L, Kopecek M, Novak T, Hoschl C, Alda M. Structural plasticity of the right inferior frontal gyrus in the course of bipolar disorders - interplay between compensatory changes, illness burden and lithium treatment. 50th Annual Meeting of American College of Neuropsychopharmacology, Dec 4-8, 2011. Waikoloa, Hawaii, USA
  20. Brunovský M, Horáček J, Tišlerová B, Novák T, Šóš P, Španiel F, Höschl C. Ketamine model of schizophrenia: QEEG and sLORETA study in healthy volunteers.In Neuroimaging through the lifespan: Brain development and brain diseases from adolescence to senescence. Joint meeting of ISNIP/ISBET/ECNP. Heidelberg: ISNIP, 2011; s. 15.
  21. Csémy L, Prajsová J, Mohr P, Höschl C. Epidemiology of generalized anxiety disorder (GAD) and other anxiety disorders in the Czech Republic.European Psychiatry, 2011; 26(Suppl. 1): 524.
  22. Brunovský M., Horáček J., Novák T., Šóš P., Kohútová B., Krajča V., Höschl C. QEEG measured changes of neuronal activity and brain connectivity induced by i.v. administration of ketamine in healthy volunteers and patients with depressive disorder. Psychiatrie, 16; 2012, S1:36.
  23. Höschl C, Fialová L. Conflict of interest in psychiatry. Eur. Psychiatry 2012; 27(1): CS05-02
  24. Bares M, Novak T, Höschl C.: Prediction of therapeutic outcome in treatment resistant depression. Eur. Psychiatry 2012; 27(1): CS02-02
  25. Kopecek M, Bares M, Novak T, Brunovsky M, Stopkova P, Krajca V, Höschl C.: Can we use changes in prefrontal function to predict antidepressant response in bipolar disorder? Eur. Psychiatry 2012; 27(1): AS 06-02
  26. Brunovsky M, Bares M, Kopecek M, Horacek J, Novak T, Sos P, Höschl C.: Reduction of prefrontal theta cordance in the prediction of response to antidepressants. Eur. Psychiatry 2012; 27(1): AS21-04
  27. Horacek J, Brunovsky M, Klirova M, Novak T, Tintera J, Höschl C.: Effect of low-frequency rTMS on electromagnetic tomography (LORETA) and regional brain metabolism (PET) in schizophrenia patients with auditory hallucinations. Eur. Psychiatry 2012; 27(1): AS21-03
  28. Höschl C. Bedřich Smetana - Art and Disease [in Czech] (2012). Lekársky obzor, LXI; S1:2-4. ISSN 0457-4214
  29. Höschl C. Sociobiology of depression [in Czech] (2012). Lekársky obzor, LXI; S1:14-15. ISSN 0457-4214
  30. Páleníček T, Horáček J, Brunovský M, Fujáková M, Tylš F, Höschl C. Neurobiology of effect of psychedelics and its' use in research and clinical practice [in Czech]. Lekársky obzor, LXI; S1:15. ISSN 0457-4214
  31. Brunovský M, Bareš M, Kopeček M, Novák T, Šóš P, Höschl C. Prediction of therapeutic response to antidepressants using QEEG cordance [in Slovak]. Lekársky obzor, LXI; S1:16. ISSN 0457-4214
  32. Šóš P, Klírová M, Horáček J, Novák T, Brunovský M, Höschl C. Quantitative EEG in prediction of antidepressive effect of ketamine [in Slovak]. Lekársky obzor, LXI; S1:16. ISSN 0457-4214
  33. Hajek T, Kopecek M, Hoschl C, Alda M. Reduced hippocampal volumes in bipolar disorders are masked by exposure to lithium - meta-analysis. P-16-008, 28th CINP World Congress of Neuropsychopharmacology. Stockholm, 3-7 June 2012
  34. Stein D, Márquez MS, Höschl C, Ahokas A, Oh KS, Jarema M, Avedisova A, Vavrusova L, Olivier V. Efficacy and tolerability of agomelatine in generalized anxiety disorder (GAD): A randomised double-blind, placebo-controlled trial with escitalopram as validator. P-04-019, 28th CINP World Congress of Neuropsychopharmacology. Stockholm, 3-7 June 2012
  35. Höschl C. How will we treat depression and anxiety in ten years? In: Raboch J. et al.(eds.), Sborník příspěvků (abstract book), IX. Congress of the Czech Psychiatric Society, pp. 18-20. Tribun EU 2012, ISBN 978-80-263-0243-8
  36. Bareš M, Novák T, Brunovský M, Stopková P, Höschl C. The prediction of response to antidepressive interventions in patients with bipolar depression - the change of QEEG cordance. In: Raboch J. et al.(eds.), Sborník příspěvků (abstract book), IX. Congress of the Czech Psychiatric Society, pp. 18-20. Tribun EU 2012, ISBN 978-80-263-0243-8
  37.  Höschl C.: Sigmund Freud and contemporary medicine. Psych. Danubina 2012; vol. 24, S1:204
  38.  Brunovsky M, Bares M, Novak T, Kopecek M, Sos P, Koprivova J, Krajca V & Höschl C.: The change of QEEG prefrontal theta cordance in the prediction of response to antidepressants. Psych. Danubina 2012; vol. 24, S1:205
  39. Höschl C. Integrating psychiatry within new medical curriculum. Čes. Slov. Psychiatrie, 108, 2012; S1:28
  40. Höschl C.: Placebo - deception or indispensable tool? Abstract book of the Student's scientific conference "Ageing 2012", Praha 26-27 Oct 2012 [in Czech], p. 17.
  41. Höschl C.: Principles of antidepressant pharmacotherapy in light of personalized medicine. Psychiatrie 17; 2013, S1:19. 55th Czech-Slovak psychopharmacological conference in Jeseník, 4.-8.1.2013.
  42. Bareš M., Novák T., Brunovský M., Kopeček M., Höschl C.: Prediction of treatment response to antidepressants in patients with treatment resistant depression- a combined model. Psychiatrie 17; 2013, S1:20-21. 55th Czech-Slovak psychopharmacological conference in Jeseník, 4.-8.1.2013.
  43. Horáček J., Brunovský M., Novák T., Šóš P., Páleníček T., Fujáková M., Höschl C.: Ketamine in models of psychoses. Psychiatrie 17; 2013, S1:29. 55th Czech-Slovak psychopharmacological conference in Jeseník, 4.-8.1.2013.
  44. Brunovský M., Horáček J., Šóš P., Novák T., Bareš M., Kohútová B., Höschl C.: Electrophysiological correlates of ketamine effect in depression and in healthy volunteers. Psychiatrie 17; 2013, S1:31. 55th Czech-Slovak psychopharmacological conference in Jeseník, 4.-8.1.2013.
  45. Höschl C, Fialová L. EPA Guidance Paper on Conflict of Interest. Abstract 2395, Eur Psychiatry, abstracts of 21st European Congress of Psychiatry, 6-9 April 2013, Nice, France.
  46. Höschl C. Why do some psychotropic drugs work and some others don´t? Abstract 2393, Eur Psychiatry, abstracts of 21st European Congress of Psychiatry, 6-9 April 2013, Nice, France.
  47. Höschl C. Burnout is a myth. Abstract 2394, Eur Psychiatry, abstracts of 21st European Congress of Psychiatry, 6-9 April 2013, Nice, France.
  48. Hood S, Stein D, Marquez M, Hoschl C, Ahokas A, Oh K, Jarema M, Avedisova A, Vavrusova L, Oliver V. Efficacy of the antidepressant agomelatine in generalised anxiety disorder: a randomised, double-blind, placebo-controlled trial versus active comparator. Australian and New Zealand Journal of Psychiatry, 47, 2013; S1: 49-49
  49. Špeniel F, Hrdlička J, Bakštein E, Novák T, Höschl C. Information technology aided relapse prevention program in schizophrenia. Psychiatria Danubina, 2013; 25, S2: 407
  50. Španiel F, Tintěra J, Ibrahim I, Rydlo J, Horáček J, Höschl C. Abnormality in the neural correlate of self-agency experience in first-episode schizophrenia patients. A fMRI study. Psychiatria Danubina, 2013; 25, S2: 407
  51. Brunovský M, Horáček J, Šóš P, Páleníček T, Höschl C. Clinical and Pharmaco-EEG changes after a single intravenous infusion of ketamine in patients with treatment-resistant unipolar depression. Psychiatria Danubina, 2013; 25, S2: 371
  52. Horáček J, Mikoláš P, Tintěra J, Brunovský M, Höschl C, Alda M. The opposite effect of mood induction on amygdala response to emotional stimuli in bipolar patients and healthy controls: fMRI study. Psychiatria Danubina, 2013; 25, S2: 371-372
  53. Höschl C. Placebo and pain. VI. interdisciplinary congress of the Czech Medical Academy "Pain across medicine". Karlovy Vary (Carlsbad), 24-26 Oct 2013
  54. Bares M, Novak T, Brunovsky M, Kopecek M, Höschl C. Early improvement of depressive symptoms and reduction of prefrontal cordance as predictors of response to Venlafaxine ER in patients with resistant depression. Abstracts of the 22nd European Congress of Psychiatry, Eur. Psychiatry, Article: EPA-0204
  55. Sos P, Klirova M, Novak T, Brunovsky M, Horacek J, Hoschl C. Rapid Antidepressant Effect of NMDA Antagonist and QEEG Biomarker of Sustained Response. Abstracts of the 22nd European Congress of Psychiatry, Eur. Psychiatry, Article: EPA-1261
  56. Höschl C, Španiel F. Art and neuroscience. On evolutionary meaning of art and its neurobiological relevance. Abstract of a lecture on International conference 4th Young Psychiatrists’ Network Meeting „A coin with many sides: different perspectives on mental illness“. Wrocław, Poland, April 3-5, 2014
  57. Höschl C. Freud and contemporary medicine. Abstracts, 4th Slovak Neuropsychiatric congress with International participation. Lekarsky obzor [Medical horizon], LXIII, 2014;S1:12
  58. Höschl C, Španiel F. Art and neuroscience. On evolutionary meaning of art and its neurobiological relevance. Abstracts, 4th Slovak Neuropsychiatric congress with International participation. Lekarsky obzor [Medical horizon], LXIII, 2014;S1:12-13
  59. Brunovský M, Horáček J, Šóš P, Páleníček T, Novák T, Klírová M, Höschl C. Pharmaco EEG study of ketamine in patients with major depressive disorder: QEEG and clinical predictors of antidepressive response. 18th Biennial Conference, September 25th-28th 2014, Leipzig, Germany, 2014, 38.
  60. Šóš P., Klirová M., Novák T., Brunovský M., Horáček J., Höschl C. Clinical and neurophysiological biomarkers of ketamine´s antidepressant effect in major depressive disorder patients. Berlin, Bermany, 18.10.-21.10.2014. European Neuropsychopharmacology, 2014, 24 (Suppl. 2), S467. ISSN: 0924-977X.
  61. Höschl C.: Placebo - deception or indispensable tool? Abstract book, XVIth Symposium of clinical pharmacy of René Mach, Mikulov, 21.-22.2014
  62. Höschl C., Freud and contemporary medicine. Ostrava, 18.11.2014 - 22.11.2014. Czech and Slovak Neurology and Neurosurgery, 2014, 77 (Suppl).
  63. Horáček J, Brunovský M, Novák T, Tintěra J, Ibrahim I, Španiel F, Klírová M, Tišlerová B, Höschl C. Ketamin in schizophrenia modeling. Psychiatrie, 19;2015(S1):12-13
  64. Španiel F, Horáček J, Tintěra J, Ibrahim I, Rydlo J, Matějka M, Mertlová M, Slováková A, Görnerová N, Höschl C. Genetic influence on grey matter volume in schizophrenia. Psychiatrie, 19;2015(S1):15-16.
  65. Höschl C, Švestka J. Next generation of psychotropic drugs: Antidepressants. Psychiatrie, 19;2015(S1):25
  66. Androvičová R, Horáček J, Páleníček T, Tintěra J, Rydlo J, Höschl C, Balíková M. The effect of cannabinoids on a brain response to visual intimate erotica - fMRI study. Psychiatrie, 19;2015(S1):35-36.
  67. Bareš M, Novák T, Höschl C. Prediction of the therapeutic outcome. Eur Psychiatry, abstracts of the 23rd European Congress of Psychiatry, Vienna, Austria 28-31 March 2015. Article 0056.
  68. Španiel F, Tintěra R, Rydlo J, Ibrahim I, Horáček J, Kašpárek T, Höschl C. Anti-correlated brain networks and self-agency experience in first-episode schizophrenia - spectrum patients. An FMRI study. Eur Psychiatry, abstracts of the 23rd European Congress of Psychiatry. Vienna, Austria 28-31 March 2015. Article 0897.
  69. Brunovský M., Viktorinová M., Horáček J., Bareš M., Novák T., Bravermanová A., Šóš P, Höschl C.: QEEG correlates of autobiographically- induced emocionally negative state (sadness) in patients with bipolar affective disorder and healthy controls. Psychiatrie, 2015, 19; Suppl. 2: 32-33.
  70. Höschl C, Španiel F. Information Technology Aided Relapse Prevention in Schizophrenia (ITAREPS). 12th World Congress of Biological Psychiatry, 14-18 June 2015, Athens, Greece. WS-11-002
  71. Höschl C. Is ADHD a historical novelty? 5th Biennial Cambridge & Bedford International Conference on Mental Health. Clare College, Cambridge University 11-14 Sept 2015
  72. Winkler P, Mladá K, Krupchanka D, Agius M, Manaan Kar-Ray, Höschl C. Long term inpatients with psychoses discharged from Czech mental hospitals in 2006-2011. Abstracts of the 5th Biennial Cambridge & Bedford International Conference on Mental Health. Clare College, Cambridge University 11-14 Sept 2015
  73. Brunovsky M, Horacek J, Viktorinova M, Novak T, Bravermanova M, Goetz M, Höschl C. QEEG signatures of remitted bipolar patients and offspring of bipolar parents. Abstracts of the 5th Biennial Cambridge & Bedford International Conference on Mental Health. Clare College, Cambridge University 11-14 Sept 2015
  74. Horacek J, Novak T, Brunovsky M, Klirova M, Zaytseva Y, Spaniel F, Koprivova J, Bravermanova A, Höschl C. From functional neuroanatomy to the stereo-selective treatment: rTMS in schizophrenia. Abstracts of the 5th Biennial Cambridge & Bedford International Conference on Mental Health. Clare College, Cambridge University 11-14 Sept 2015
  75. Androvičová R, Horáček J, Tintěra J, Rydlo J, Páleníček T, Balíková M, Ježová D, Höschl C. Activation of brain reward areas by visual erotic stimuli in relation to the effects of cannabis. Abstracts of the 5th Biennial Cambridge & Bedford International Conference on Mental Health. Clare College, Cambridge University 11-14 Sept 2015.
  76. Höschl C. Is ADHD a historical novelty? 25th Annual Meeting of European Network of Teratology Information Services. Praha, 18-20 September 2015
  77. Šóš P, Klírová M, Novák T, Bareš M, Valeš K, Kletečková L, Říčný J, Páleníček T, Kuchař M, Brunovský M, Horáček J, Höschl C. Oscilatory synchrony and neuroplasticity in neurobiology of mechanism of antidepressant response. Psychiatrie, 20; 2016, S1:31
  78. Winkler P, Krupchanka D, Mladá K, Agius M, Kar Ray M, Höschl C. Long-term hospitalizations for schizophrenia in CR 1998-2012. Psychiatrie, 20; 2016, S1:33
  79. Androvičová R, Horáček J, Tintěra J, Rydlo J, Páleníček T, Balíková M, Žilavá L, Ježová D, Mikšátková P, Hlinka J, Höschl C. Differences in brain rersponse to visual erotica in casual marijuana users, chronic marijuana users and non-users (fMRI study). Psychiatrie, 20; 2016, S1:42
  80. Brunovský M, Horáček J, Viktorinová M, Novák T, Bravermanová A, Goetz M, Höschl C. gEEG biomarkers of remitted bipolar patients and offspring of bipolar parents. Psychiatrie, 20; 2016, S1:43
  81. Androvičová R, Horáček J, Páleníček T, Tintěra J, Rydlo J, Balíková M, Hložek T, Ježová D, Hlinka J, Mikšátková P, Höschl C: The dirrection of nucleus accumbens response to erotic stimuli depends on individual prolactin reactivity to marijuana intoxication: implication for the treatment of a disorder of sexual desire (fMRI study). XXVIII. Bohnice Sexological Days
  82. Höschl C, Horáček J. Duše jako imunomodulátor [Mind as a neuromodulator]. VI. Czech-Slovak neuropsychiatric symposium, Červený Kláštor, Slovakia, 27.-28.5.2016
  83. Brunovský M, Horáček J, Viktorinová M, Novák T, Šebela A, Goetz M, Höschl C. EEG changes in bipolar patients and their offsprings: search for a biomarker. Proceedings of the VI. Czech-Slovak neuropsychiatric symposium. Červený Kláštor, Slovakia, 27.-28.5.2016.
  84. Bareš M, Novák T, Brunovský M, Kopeček M, Höschl C. Plasma and serum levels of BDNF in the prediction of response to antidepressants in depressive patients. In: Anders M. et al. (eds.): XI. Meeting of the Czech Psychiatric Association of the Czech Medical Society of Jan Evangelista Purkyně, Špindlerův Mlýn, 9.-12.6.2016, abstract book, pp.213-216. ISBN 978-80-263-1047-1
  85. Androvičová R.,Horáček J.,Tintěra J.,Rydlo J.,Páleníček T. ...Höschl C.: The effect of marijuana intoxication on the dirrection of nucleus accumbens response to erotic stimuli depends of individual prolactin reactivity: analysis of variables which determine it in casual users and comparison to chronic users and non-using controls (fMRI study). Book of Abstr.Intern. Academy of Sex Resarch 2016,63.
  86. Höschl C. Pain of soul. Invited lecture on the conference of the company Svet zdravia, a.s., entitled "Hospital without pain". Jasná, Slovakia 8 Nov 2016, abstract in the printed programme.
  87. Höschl C. Mind as an immunomodulator. Invited lecture on the conference of the company Svet zdravia, a.s., entitled "Hospital without pain". Jasná, Slovakia 8 Nov 2016, abstract in the printed programme.
  88. Höschl C, Horáček J. Are innovations in the antipsychotic treatment still possible? Psychiatrie, 21, 2017; S1:18-19
  89. Höschl C. Risks and hazards of veterinary medicine. (Burn-out syndrome and its prevention). Congress of Veterinary medicine for practice. Ball-house of the Prague Castle, 20 May 2017. Proceedings, p.72
  90. Höschl C. Placebo: scam or a useful tool? Keynote lecture, 22nd WONCA (World Organization of Family Doctors [World Organization of National Colleges, Academies and Academic Associations of General Practitioners/Family Physicians]) Europe Conference, Prague, 28.6.-1.7.2017
  91. Stein D, Khoo J, Van Ameringen D, Hoschl C et al. Efficacy and safety of agomelatine 25–50 mg/day versus escitalopram 10–20 mg/day in severe generalized anxiety disorder. P.4.d.001. Abstracts of 30th Congress of European College of Neuro-Psychopharmacology, Paris, 2-5 September 2017.
  92. Höschl C, Horáček J: Mind as an immunomodulator [in Czech]. Proceedings of the 17th Czech-Slovak psychiatric congress, 19–21 October 2017, Bratislava, pp. 22-23. ISBN 978-80-7492-328-9

Previous | 1 | 2 | 3  Move up